Notable Analyst Rating Changes 5/21: TGT, FCX, CME, THC, CSIQ Upgraded; PETM, VALE, POT Downgraded
UPGRADES:
UBS upgrades Target (NYSE: TGT) from Neutral to Buy. Price target $52.
JP Morgan upgrades Freeport-McMoRan (NYSE: FCX) from Neutral to Overweight.
Goldman Sachs upgrades CME Group Inc. (NYSE: CME) from Neutral to Buy and raised its price target from $215 to $330.
Barclays upgrades Tenet Healthcare (NYSE: THC) from Equalweight to Overweight.
Oppenheimer upgrades Canadian Solar (Nasdaq: CSIQ) from Perform to Outperform. Price target $14.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades PetSmart (Nasdaq: PETM) from Buy to Neutral.
Morgan Stanley downgrades Vale (Nasdaq: VALE) from Equalweight to Underweight.
TD Newcrest downgrades Potash Corp. of Saskatchewan (NYSE: POT) from Buy to Hold. Click here for more color.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Soleil Securities initiates coverage on Marriott International (NYSE: MAR) with a Buy. Price target $30.
William Blair initiates coverage on Perrigo (Nasdaq: PRGO) with an Outperform.
Soleil Securities initiates coverage on Priceline.com (Nasdaq: PCLN) with a Hold. Price target $112.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Create E-mail AlertRelated Categories
Special ReportsStocks Mentioned
-0.59
+0.22Related Entities
- UBS
- William Blair
- JPMorgan
- Goldman Sachs
- Morgan Stanley
- Soleil Securities
- Barclays
- TD Newcrest
- Notable Analyst Rating Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
